Associated tags: Sales, Civica, Patient, Health, Pharmaceutical industry, Pharmaceutical, Insulin, Diabetes, Hospitals, Managed Care
Locations: SPAIN, UNITED STATES, NORTH AMERICA, VIRGINIA
Retrieved on:
Wednesday, November 1, 2023
Biotechnology,
Pharmaceutical,
Health,
Medical Supplies,
Civica,
Quality,
Takeda,
Sage,
Inc.,
Therapy,
Patient,
Insulin,
Medical device Civica Inc. (Civica, Civica Rx) is proud to announce that pharmaceutical industry leader Bouwien Smits has joined Civica as the new Site Vice President and General Manager of the company’s new sterile injectable manufacturing facility.
Key Points:
- Civica Inc. (Civica, Civica Rx) is proud to announce that pharmaceutical industry leader Bouwien Smits has joined Civica as the new Site Vice President and General Manager of the company’s new sterile injectable manufacturing facility.
- Smits has over 25 years of experience, including working with aseptic products and injectable drugs, alongside critical expertise in facility and equipment qualification, system implementation, and process validation.
- “Bouwien is joining us at a critical moment in the startup process for Civica’s first manufacturing facility,” said Jay Benson, Civica’s Chief Manufacturing and Supply Chain Officer.
- “The Petersburg facility will be transformative for ensuring safe and reliable supplies of medicines for hospital systems and patients and for bringing much needed affordability into the insulin marketplace.”
Prior to joining Civica, Smits was Vice President of Quality at Sage Therapeutics.
BARCELONA, Spain, Aug. 22, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Civica Rx (Civica) has adopted Veeva Vault LIMS to optimize quality control. Vault LIMS builds on Civica's success with Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training and establishes a foundation for unified lab and quality processes to support a new manufacturing facility.
Key Points:
- BARCELONA, Spain, Aug. 22, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Civica Rx (Civica) has adopted Veeva Vault LIMS to optimize quality control.
- Vault LIMS builds on Civica's success with Veeva Vault QMS , Veeva Vault QualityDocs , and Veeva Vault Training and establishes a foundation for unified lab and quality processes to support a new manufacturing facility.
- Within Vault LIMS, lab professionals will be able to reference relevant methods and specifications stored in Vault QualityDocs and surface relevant quality events from Vault QMS during final QC review.
- "Veeva Vault LIMS will help Civica create an advanced quality control lab with a simple and efficient user experience," said Jason Boyd, senior director, Veeva Vault LIMS.
Medical Supplies,
Biotechnology,
Manufacturing,
Managed Care,
Diabetes,
Health,
Philanthropy,
Pharmaceutical,
Other Philanthropy,
Other Manufacturing,
Hospitals,
Benson,
Inc.,
Takeda,
Thermo Fisher Scientific,
Bayer,
Global Operations,
Retirement,
Hospital,
Patient,
United,
Pharmaceutical industry,
Medical device,
Civica Civica Inc. (Civica, Civica Rx) today announced that biopharma industry veteran Jay Benson has joined Civica as Chief Manufacturing and Supply Chain Officer.
Key Points:
- Civica Inc. (Civica, Civica Rx) today announced that biopharma industry veteran Jay Benson has joined Civica as Chief Manufacturing and Supply Chain Officer.
- Benson has 30 years of experience within the biopharmaceutical industry, including clinical and commercial manufacturing, global strategy development, and tech transfer and commercialization of new therapies.
- “Jay takes the torch from Russ Gall, who has been with Civica from inception,” added McCoy.
- “We thank Russ for his many years of service to Civica, our partners and patients and wish him well in his retirement.”
Public Policy,
Government,
Pharmaceutical,
State,
Local,
Managed Care,
Health,
Diabetes,
Healthcare Reform,
Hospitals,
Insulin,
Inc.,
Partnership,
Insulin lispro,
Patient,
Risk,
Insulin aspart,
Pharmaceutical industry,
Civica,
Insulin glargine Civica Inc. (Civica, Civica Rx) today announced it will manufacture insulins for the State of California’s CalRx Biosimilar Insulin Initiative as part of its insulin manufacturing work.
Key Points:
- Civica Inc. (Civica, Civica Rx) today announced it will manufacture insulins for the State of California’s CalRx Biosimilar Insulin Initiative as part of its insulin manufacturing work.
- “California’s partnership with Civica is a game changer,” said California Governor Gavin Newsom.
- Civica and CalRx have the mutual goal of ensuring access to affordable insulins that have single, low transparent prices.
- The next phase of this partnership is assessing options for the standup of an insulin manufacturing facility in California and further efforts to disrupt the insulin market and provide additional benefits for patients who depend on this life saving drug.
Retrieved on:
Tuesday, January 31, 2023
Biotechnology,
Diabetes,
Other Health,
Health,
Pharmaceutical,
FDA,
Insulin lispro,
Insulin,
Pharmaceutical industry in Switzerland,
Pharmaceutical industry,
Civica Civica, Inc. (Civica, Civica Rx) today announced the selection of Ypsomed AG as the manufacturer and supplier of insulin dosing injector pens for Civica’s affordable insulins.
Key Points:
- Civica, Inc. (Civica, Civica Rx) today announced the selection of Ypsomed AG as the manufacturer and supplier of insulin dosing injector pens for Civica’s affordable insulins.
- To ensure redundancy of supply, Ypsomed will provide injector dosing pens from their two manufacturing facilities in Switzerland and Germany.
- “As a renowned injection device specialist with over 35 years’ experience, Ypsomed will help Civica make self-administered care more affordable for Americans living with diabetes,” said Ned McCoy, President and Chief Executive Officer of Civica.
- Contingent on FDA approval, Civica anticipates that its insulins will be available for purchase beginning as soon as 2024.
Medical Supplies,
Manufacturing,
Managed Care,
Health,
Other Transport,
General Health,
Pharmaceutical,
Transport,
Other Manufacturing,
Hospitals,
Logistics,
Supply Chain Management,
Federation,
AmerisourceBergen,
Multimedia,
COVID-19,
Patient,
Partnership,
Pharmaceutical industry,
Nursing,
Civica Starting today, global healthcare company AmerisourceBergen will serve as Civica, Inc.’s (Civica) exclusive distribution partner and provide supply chain support for Civica’s products and a best-in-class customer experience for Civica members.
Key Points:
- Starting today, global healthcare company AmerisourceBergen will serve as Civica, Inc.’s (Civica) exclusive distribution partner and provide supply chain support for Civica’s products and a best-in-class customer experience for Civica members.
- Through its distribution network, AmerisourceBergen will work to ensure that Civica’s crucial products reach its members across the country efficiently, reliably, and securely.
- View the full release here: https://www.businesswire.com/news/home/20230123005078/en/
“We are thrilled to have AmerisourceBergen as our like-minded distribution and supply chain partner as we continue to grow our hospital network,” said Ned McCoy, President and CEO of Civica.
- More than 1,500 pharmaceutical manufacturers and tens of thousands of healthcare providers rely on AmerisourceBergen every day to deliver critical medicines and treatments.
Health,
General Health,
Company,
Hospital,
Mayo Clinic,
Blue Cross Blue Shield Association,
Â,
SSM Health,
Patient,
Chemical engineering,
Health,
North Carolina State University,
AbbVie,
McCoy,
Intermountain Healthcare,
Trinity,
CommonSpirit Health,
Culture,
Trinity Health,
Retirement,
Critical care,
Medication,
Partnership,
Board,
Hospital Productions,
Insulin,
Board of directors,
Bachelor,
Dan Liljenquist,
HCA Healthcare,
Growth,
Blue Cross,
Abbott,
Management,
Science,
Civica,
Director Civica, Inc. (Civica, Civica Rx) today announced that Ned McCoy, currently Civicas Chief Operating Officer, will succeed Martin VanTrieste as Civicas President and Chief Executive Officer, effective June 1.
Key Points:
- Civica, Inc. (Civica, Civica Rx) today announced that Ned McCoy, currently Civicas Chief Operating Officer, will succeed Martin VanTrieste as Civicas President and Chief Executive Officer, effective June 1.
- As part of this transition, McCoy will also join the Civica Board of Directors on June 1.
- Civica, Inc. (Civica, Civica Rx) is a nonprofit generic pharmaceutical company.
- Hospital advisorsdoctors and pharmacistsprioritize the essential medicines Civica provides for use in acute and critical care, emergency rooms, and surgery.
Diabetes,
Open Insulin Project,
Medicaid,
Family,
Patient,
Adult,
Korea Disease Control and Prevention Agency,
Population,
Severe cognitive impairment,
Insulin,
Public health,
National,
Blue Cross Blue Shield Association,
News,
Medicare,
American Diabetes Association,
Civica,
Friends,
Kidney failure,
Disease,
Blue Shield,
Pharmacy,
CEO,
Center,
Foundation for the National Institutes of Health,
Pharmaceutical industry,
Health insurance The insulin initiative is supported by a wide range of health systems and health plans, including Blue Shield of California and several other independent Blue Cross Blue Shield companies.
Key Points:
- The insulin initiative is supported by a wide range of health systems and health plans, including Blue Shield of California and several other independent Blue Cross Blue Shield companies.
- "This initiative will put affordable insulin within reach of every Californian who needs it and help reduce healthcare spending driven by runaway prescription drug prices."
- Blue Shield of California strives to create a healthcare system worthy of its family and friends that is sustainably affordable.
- The company has contributed more than $500 million to Blue Shield of California Foundation since 2002 to have an impact on California communities.
Vantage will implement Civica's MDM solution, MultiVue, to improve quality of care by creating a complete, accurate and shareable view of its members, patients and providers.
Key Points:
- Vantage will implement Civica's MDM solution, MultiVue, to improve quality of care by creating a complete, accurate and shareable view of its members, patients and providers.
- They sought a partner who could help create a single view of the patient and member across Vantage's networks of hospitals, clinics, labs and pharmacies.
- "An Enterprise Master Patient Index (EMPI) is foundational to our mission of improving the quality of care for our beneficiaries.
- Vantage will use MultiVue to share images, Continuity of Care Documents and other patient data with provider partners.
Civica's MDM technology offers a complete, accurate view of patient records, providing the clean, robust data necessary to enable healthcare innovators to power their predictive analytics and AI technology.
Key Points:
- Civica's MDM technology offers a complete, accurate view of patient records, providing the clean, robust data necessary to enable healthcare innovators to power their predictive analytics and AI technology.
- HealthReveal helps ensure patients receive optimal, personalized care, using artificial intelligence to apply the latest medical guidelines to individual patient health data.
- HealthReveal's clinical AI solution relies on accurate patient data, and our MDM solution provides a single, accurate, and complete view of the patient, ensuring the highest degree of data reliability," said Chris Owen, Divisional Managing Director, Digital and Data Solutions at Civica.
- "HealthReveal's volume of data is rapidly expanding," added Lori Evans Bernstein, MPH, Co-founder and Chief Operating Officer of HealthReveal.
